PO.TB10.03 · 肿瘤生物学
Microenvironmental Determinants of Therapy Response and Resistance 1
- 3429 3429 巨噬细胞通过增加肿瘤细胞脂质可用性促进肝细胞癌的免疫治疗耐药 Macrophages promote immunotherapy resistance of hepatocellular carcinoma through increasing tumor cell lipid availability Zhixian Liang, Xiaohang LONG, ZHEWEN XIONG, PATRICK WONG, Siyuan HUANG, Siyun Chen, Yiling Zhang, Lingyun ZHANG, Chunning Leung, Saiming Ngai, Stephen Lam CHAN, Alfred S. L. Cheng
- 3430 3430 NR4A3作为肿瘤相关巨噬细胞中的免疫代谢检查点介导直肠癌的放疗敏感性 NR4A3 functions as an immuno-metabolic checkpoint in tumor-associated macrophages to mediate radiotherapy sensitivity in rectal cancer Xiaowan Guo, Gan Tao, Xiuli Guo, Kehua Hu, Rurui Xue, Yunli Mo, Hui Qiu, Qiuji Wu
- 3431 3431 高表达CXCL2的中性粒细胞样单核细胞(NeuMos)协调全身粒细胞生成并驱动TNBC免疫治疗耐药 Neutrophil-like monocytes (NeuMos) with high levels of CXCL2 expression orchestrate systemic granulopoiesis and drive immunotherapy resistance in TNBC Fulya Alkan, Hilmi K. Alkan, Ahmet Caglayan, Aysun Caglayan, Aminah Lawal, Neva Celiker, Huidong Shi, Thomas Vogl, Nouri Neamati, Wicha Max, Hasan Korkaya
-
3432 · PDF M2巨噬细胞在上皮性卵巢癌肿瘤微环境化疗耐药中的作用 Role of M2 macrophages in chemoresistance about the tumor microenvironment of epithelial ovarian cancer Jaesung Ryu, Baek MooJun, HyoWook Gil, Eunjung Yang, Kwangseock Kim, Taewan Kim, Kong Hyejeong, Beamjun Park, Seob Jeon
-
3433 · PDF 肿瘤相关巨噬细胞的新分类及其在免疫检查点治疗耐药中的作用 A new classification of tumor-associated macrophages and their roles in resistance to immune checkpoint therapy Bryan T. Weselman, Satish Kumar Reddy Noonepalle, Manasa Suresh, Alexandra Singh, Isabella Duchovny, Xintang Li, Mackenna Ward, Alejandro Villagra
- 3434 3434 空间分辨多组学分析揭示PARP抑制和PD-L1阻断期间BRCA依赖性免疫重塑 Spatially resolved multi-omic profiling reveals BRCA-dependent immune remodeling during PARP inhibition and PD-L1 blockade Kenichi Shimada, Filipa Lynce, Claudine Isaacs, Xue Geng, Edward T. Richardson, Candace Mainor, Mei Wei, Julie M. Collins, Paula R. Pohlmann, Arielle L. Heeke, Kelly F. Zheng, Madeline Townsend, Lauren M. Sloat, Jane Staunton, Stuart J. Schnitt, Hongkun Wang, Joan S. Brugge, Geoffrey I. Shapiro, Jennifer L. Guerriero
- 3435 3435 空间转录组分析揭示与肺腺癌免疫检查点阻断反应相关的独特肿瘤微环境重塑模式 Spatial transcriptomic profiling reveals distinct tumor microenvironment remodeling patterns associated with immune checkpoint blockade response in lung adenocarcinoma Heesoo Yoon, Jin-Wook Choi, Sejoon Lee, Jin-Haeng Chung, Hyojin Kim
-
3436 · PDF 非小细胞肺癌(NSCLC)中细胞休眠程序的新兴证据 Emerging evidence of cellular dormancy programs in non-small cell lung cancer (NSCLC) Grace Ha, Melissa Tracy, Anthony Griffen, Daniel Bravo, Dior Dedushi, Terence Li, David Schecter, Neel Chudgar, Chaoyuan Kuang, Julio Aguirre-Ghiso, Brendon Stiles, Lindsay M. LaFave
-
3437 · PDF 抗肿瘤与促肿瘤髓系细胞及Treg细胞的动态波动在环磷酰胺作用下产生 Dynamic waves of anti-and pro-tumoral myeloid and Treg cells are generated in response to cyclophosphamide Andrea Franceschini, Giovanna Talarico, Davide Lombardi, Stefania Orecchioni, Giulia Bravetti, Iros Barozzi, Paolo Falvo, Francesco Bertolini
-
3438 · PDF DNA损伤性治疗诱导促肿瘤发生的成纤维细胞表型 DNA damaging therapies induce a pro-tumorigenic fibroblast phenotype Emily Lay, Mikal Negasi, Ben Flynn, Tressan Grant, Ioanna Kontou, Gernot Walko, Ute Jungwirth
- 3439 3439 白蛋白结合型紫杉醇诱导的基质重编程驱动PDAC对AG新辅助化疗的耐药 Albumin-bound paclitaxel induced stromal reprogramming drives PDAC resistance to AG neoadjuvant chemotherapy Haorui Li, Tiansuo Zhao, Xi Ma, Xiang He, Hongji Dai, Bin Wang
-
3441 · PDF 雄激素驱动的性别二态性重塑免疫串扰并限制PDAC对免疫治疗的应答 Androgen-driven sexual dimorphism reshapes immune crosstalk and limits immunotherapy response in PDAC Sonia Mecorapaj, Tenzin Passang, Fanyuan Zeng, Zihan Chen, Shuhua Wang, Tuisha Gupta, Shayna Jankowski, Jian-Ming Li, Cynthia R. Giver, Swapnaa Balaji, Kiranj Chaudagar, Edmund K. Waller
-
3442 · PDF 弥漫性星形细胞瘤治疗后复发与进展背景下的肿瘤免疫微环境(TiME)演化 TiME evolution in the context of diffuse astrocytoma post-therapy relapse and progression Aliisa Tiihonen, Iida Salonen, Ella Raulamo, Eelis Mikkonen, Emilia Mäki, Maria Annala, Tomi Hoikka, Ismaïl Hermelo, Anna Dénes, Thomas Olsson Bontell, Helena Carén, Asgeir Jakola, Hannu Haapasalo, Kirsi Rautajoki
-
3443 · PDF 转移性三阴性乳腺癌在免疫治疗期间肿瘤与微环境的共同演化 Tumor and microenvironmental co-evolution in metastatic triple-negative breast cancer during immunotherapy Seongyeol Park, Manon de Graaf, Artem Lomakin, Zhicheng Ma, Noah F. Greenwald, Lise Mangiante, Clemens L. Weiss, Brennan Geti Simon, Michael Angelo, Marleen Kok, Christina Curtis
- 3444 3444 I期临床试验中复发性胶质母细胞瘤的空间谱分析揭示脑室内CAR T治疗诱导的有利免疫重塑 Spatial profiling of recurrent glioblastoma in a Phase I clinical trial reveals favorable immune remodeling induced by intracerebroventricular CAR T therapy Wesley V. Wilson, MacLean P. Nasrallah, Nakial Cross, Yael A. Day, Vanessa Gonzalez, Rachel M. Leskowitz, Amy Marshall, Julie K. Jadlowsky, Gabriela Plesa, Donald L. Siegel, Elizabeth O. Hexner, Joseph A. Fraietta, Carl H. June, Stephen J. Bagley, Donald O’Rourke, Zev Binder, Andrew J. Rech
-
3445 · PDF 星形胶质细胞对放疗抵抗性胶质母细胞瘤进行重编程,揭示新的治疗易感性 Astrocytes reprogram radiation-resistant glioblastoma to reveal new therapeutic vulnerabilities Rana Abdelgawad, Andrew Dhawan
-
3446 · PDF Loxl2驱动中性粒细胞介导的免疫逃逸及小鼠黑色素瘤对抗PD-1治疗的抵抗 Loxl2 drives neutrophil-mediated immune evasion and resistance to anti PD-1 therapy in murine melanoma Jiah Yang, Emre Arslan, Veena Kochat, Suresh Satpati, Kunal Rai
- 3447 3447 由应激信号调控的III型胶原通过诱导肿瘤休眠和重塑免疫抑制性生态位驱动胰腺癌化疗抵抗 Type III collagen regulated by stress signaling drives chemoresistance in pancreatic cancer by inducing tumor dormancy and remodeling the immunosuppressive niche Haiyan Xu, Yicheng Zhou, Shengbai Xue, Siming Wu, Liwei Wang
-
3448 · PDF 连续的衰老-逃逸循环驱动EGFR突变型NSCLC的基因组异质性和奥希替尼抵抗 Sequential senescence-escape cycles drive genomic heterogeneity and osimertinib resistance in EGFR-mutant NSCLC Nazia Jamil, Hayley McDaid, Howard D. Hosgood, Qualia Hooker, Nadjet Cornejal
- 3449 3449 细胞因子阻断结局的异质性揭示SPP1+巨噬细胞在结直肠癌肝转移免疫抑制中的可能作用 Heterogeneity in outcomes of cytokine blockade identifies plausible role for SPP1+macrophages in colorectal liver metastasis immune suppression Kristin Goodsell, Jason Carter, Sheela Damle, Xiuyun Jiang, Heidi Kenerson, Ian N. Crispe, Venu G. Pillarisetty
-
3450 · PDF 肿瘤团块休眠——免疫治疗后长期持续性黑色素瘤的潜在驱动因素? Tumor mass dormancy - a potential driver of long-term persistent melanoma after immunotherapy? Yingxiao Shi, Zoltan Maliga, Tuulia Vallius, Shishir Pant, Roxanne Pelletier, Brigette Kobs, Priyanka Solanky, Yiwen He, Eliezer M. Van Allen, Sandro Santagata, Patrick Ott, Christine G. Lian, Elizabeth I. Buchbinder, David Liu, Peter Karl Sorger
- 3451 3451 单细胞转录组学洞察SMARCB1缺陷型肾髓质癌中驱动对伊沙佐米联合吉西他滨和多柔比星抵抗的肿瘤与免疫动态 Single-cell transcriptomic insights into tumor and immune dynamics driving resistance to ixazomib combined with gemcitabine and doxorubicin in SMARCB1-deficient renal medullary carcinoma Kai Yu, Rebecca Tidwell, Tharakeswara Bathala, Rahul Sheth, Menuka Karki, Jianfeng Chen, Jing Qian, Fei Duan, Luigi Perelli, Melinda Soeung, Priya Rao, Arlene Siefker-Radtke, Najat Daw, Davis Ingram, Diana Shamsutdinova, Khalida Wani, Wei-Lien Wang, Alexander Lazar, Zilong Zhao, Sabitha Prabhakaran, Neus Bota, Andrew Futreal, Rare Tumor Initiative Team, Patient Mosaic Team, Liuqing Yang, Chunru Lin, Giannicola Genovese, Jianjun Gao, Linghua Wang, Nizar Tannir, Pavlos Msaouel
- 3452 3452 利用基质易感性:表达NFATC2的CAF增强化疗敏感性并揭示胰腺癌中可靶向的ERBB轴 Exploiting stromal vulnerabilities: NFATC2-expressing CAFs enhance chemotherapy sensitivity and reveal a targetable ERBB axis in pancreatic cancer Jiahao Guo, Samuele Cancellieri, Biswajyoti Sahu
-
3453 · PDF ALK+非小细胞肺癌中的巨噬细胞极化:对靶向治疗的意义 Macrophage polarization in ALK+ non-small cell lung cancer: Implications for treatment targeting Marisa E. Aikins, Abdullah Saeed, Derek Nancarrow, Peter J. Ulintz, Peggy Hsu, Yusoo Lee, Sofia Merajver, Kiran H. Lagisetty
- 3454 3454 ANXA2表达的动态改变作为新诊断胶质母细胞瘤对新辅助贝伐珠单抗应答的预测因子 Dynamic alteration of ANXA2 expression as a predictor of response to neoadjuvant bevacizumab in newly diagnosed glioblastoma Taketo Ezaki, Ryota Tamura, Yohei Yamamoto, Jun Takei, Akihiko Teshigawara, Kyoichi Tomoto, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Hikaru Sasaki, Keisuke Miyake, Toshihide Tanaka
- 3455 3455 POSTN驱动的机械转导维持CAFs中beta-catenin活性以促进黑色素瘤进展和耐药 POSTN-driven mechanotransduction sustains beta-catenin activity in CAFs to promote melanoma progression and drug resistance Jie Wang, Bruna DA SILVA SOLEY, Linli Zhou, Yuhang Zhang
- 3456 3456 使用六十重多重免疫肿瘤学面板研究原发性与复发性浆液性卵巢癌之间肿瘤免疫微环境的空间演变 Spatial evolution of the tumor immune microenvironment between primary and recurrent serous ovarian cancer using a sixty plex multiplex immuno oncology panel Hayeon Shin, Jue young Kim, Yoon Joo Kim, Yookyung Lee, Jae-Hoon Kim
-
3457 · PDF 髓源性抑制细胞通过ARID1A/AKR1C2轴介导HR+/HER2-乳腺癌的铁死亡耐药 Myeloid-derived suppressor cells mediate ferroptosis resistance in HR+/HER2- breast cancer via the ARID1A/AKR1C2 axis Guidong Chen, Jinpu Yu
-
3458 · PDF 靶向CD44-SPP1轴以克服膀胱癌的治疗耐药 Targeting the CD44-SPP1 axis to overcome therapy resistance in bladder cancer Hiba Siddiqui, Yuzhen Zhou, Jihyun Lee, Kevin Bi, Jacqueline T. Ochoa, Martin Egger, Eliezer M. Van Allen, Filipe L. De Carvalho, Kent W. Mouw